Multiple Dose Pharmacokinetic Study of Meropenem in Young Infants (less than 91 Days) With Suspected or Complicated Intra-Abdominal Infections

Trial Profile

Multiple Dose Pharmacokinetic Study of Meropenem in Young Infants (less than 91 Days) With Suspected or Complicated Intra-Abdominal Infections

Completed
Phase of Trial: Phase I/II

Latest Information Update: 28 Apr 2015

At a glance

  • Drugs Meropenem (Primary)
  • Indications Acute enterocolitis; Bacterial infections; Intra-abdominal infections
  • Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
  • Acronyms Meropenem PK
  • Most Recent Events

    • 28 Nov 2011 Primary endoints added as reported by ClinicalTrials.gov.
    • 14 May 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 14 May 2010 Actual patient number (200) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top